APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Antibacterial Peptide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Animal Antibacterial Peptide Industry Growth and Trends Forecast to 2032

2 January 202692 pages

Choose your research edition.

Industry ResearchAnimal Antibacterial Peptide Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Antibacterial Peptide Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Animal Antibacterial Peptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Antibacterial Peptide Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Antibacterial Peptide Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Animal Antibacterial Peptide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Animal Antibacterial Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Animal Antibacterial Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal Antibacterial Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Animal Antibacterial Peptide include Animal Medics, Biogenesis Bago, Boehringer Ingelheim Vetmedica, Elanco (Eli Lilly and Company), Merial, Zoetis, Bayer HealthCare and Merck Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Animal Antibacterial Peptide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Animal Antibacterial Peptide market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Animal Antibacterial Peptide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Animal Antibacterial Peptide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Animal Antibacterial Peptide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Animal Antibacterial Peptide Market by Company

Animal Medics

Biogenesis Bago

Boehringer Ingelheim Vetmedica

Elanco (Eli Lilly and Company)

Merial

Zoetis

Bayer HealthCare

Merck Animal Health

Animal Antibacterial Peptide Segment by Type

Anionic Peptides

Cationic Peptide

Animal Antibacterial Peptide Segment by Application

Poultry

Livestock

Animal Antibacterial Peptide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Antibacterial Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Antibacterial Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Antibacterial Peptide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Animal Antibacterial Peptide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Animal Antibacterial Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Anionic Peptides Table 2. Major Company of Cationic Peptide Table 3. Global Animal Antibacterial Peptide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Animal Antibacterial Peptide Sales by Type (2021-2026) & (K Tons) Table 5. Global Animal Antibacterial Peptide Sales Market Share in Volume by Type (2021-2026) Table 6. Global Animal Antibacterial Peptide Sales by Type (2021-2026) & (US$ Million) Table 7. Global Animal Antibacterial Peptide Sales Market Share in Value by Type (2021-2026) Table 8. Global Animal Antibacterial Peptide Price by Type (2021-2026) & (US$/Ton) Table 9. Global Animal Antibacterial Peptide Sales by Type (2027-2032) & (K Tons) Table 10. Global Animal Antibacterial Peptide Sales Market Share in Volume by Type (2027-2032) Table 11. Global Animal Antibacterial Peptide Sales by Type (2027-2032) & (US$ Million) Table 12. Global Animal Antibacterial Peptide Sales Market Share in Value by Type (2027-2032) Table 13. Global Animal Antibacterial Peptide Price by Type (2027-2032) & (US$/Ton) Table 14. North America Animal Antibacterial Peptide Sales by Type (2021-2026) & (K Tons) Table 15. North America Animal Antibacterial Peptide Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Animal Antibacterial Peptide Sales by Type (2021-2026) & (K Tons) Table 17. Europe Animal Antibacterial Peptide Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Animal Antibacterial Peptide Sales by Type (2021-2026) & (K Tons) Table 19. Asia-Pacific Animal Antibacterial Peptide Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Animal Antibacterial Peptide Sales by Type (2021-2026) & (K Tons) Table 21. Latin America Animal Antibacterial Peptide Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Animal Antibacterial Peptide Sales by Type (2021-2026) & (K Tons) Table 23. Middle East and Africa Animal Antibacterial Peptide Sales by Type (2021-2026) & (US$ Million) Table 24. Animal Antibacterial Peptide Industry Trends Table 25. Animal Antibacterial Peptide Industry Drivers Table 26. Animal Antibacterial Peptide Industry Opportunities and Challenges Table 27. Animal Antibacterial Peptide Industry Restraints Table 28. Global Animal Antibacterial Peptide Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Animal Antibacterial Peptide Revenue Market Share by Company (2021-2026) Table 30. Global Animal Antibacterial Peptide Sales by Company (2021-2026) & (K Tons) Table 31. Global Animal Antibacterial Peptide Sales Share by Company (2021-2026) Table 32. Global Animal Antibacterial Peptide Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Animal Antibacterial Peptide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Animal Antibacterial Peptide Major Company Production Sites and Headquarters Table 35. Global Animal Antibacterial Peptide Company, Product Type & Application Table 36. Global Animal Antibacterial Peptide Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Animal Antibacterial Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Animal Antibacterial Peptide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Animal Antibacterial Peptide Sales by Region (2021-2026) & (K Tons) Table 41. Global Animal Antibacterial Peptide Sales Market Share in Volume by Region (2021-2026) Table 42. Global Animal Antibacterial Peptide Sales by Region (2021-2026) & (US$ Million) Table 43. Global Animal Antibacterial Peptide Sales Market Share in Value by Region (2021-2026) Table 44. Global Animal Antibacterial Peptide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Animal Antibacterial Peptide Sales by Region (2027-2032) & (K Tons) Table 46. Global Animal Antibacterial Peptide Sales Market Share in Volume by Region (2027-2032) Table 47. Global Animal Antibacterial Peptide Sales by Region (2027-2032) & (US$ Million) Table 48. Global Animal Antibacterial Peptide Sales Market Share in Value by Region (2027-2032) Table 49. Global Animal Antibacterial Peptide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Animal Antibacterial Peptide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Animal Antibacterial Peptide Sales by Application (2021-2026) & (K Tons) Table 52. Global Animal Antibacterial Peptide Sales Market Share in Volume by Application (2021-2026) Table 53. Global Animal Antibacterial Peptide Sales by Application (2021-2026) & (US$ Million) Table 54. Global Animal Antibacterial Peptide Sales Market Share in Value by Application (2021-2026) Table 55. Global Animal Antibacterial Peptide Price by Application (2021-2026) & (US$/Ton) Table 56. Global Animal Antibacterial Peptide Sales by Application (2027-2032) & (K Tons) Table 57. Global Animal Antibacterial Peptide Sales Market Share in Volume by Application (2027-2032) Table 58. Global Animal Antibacterial Peptide Sales by Application (2027-2032) & (US$ Million) Table 59. Global Animal Antibacterial Peptide Sales Market Share in Value by Application (2027-2032) Table 60. Global Animal Antibacterial Peptide Price by Application (2027-2032) & (US$/Ton) Table 61. North America Animal Antibacterial Peptide Sales by Application (2021-2026) & (K Tons) Table 62. North America Animal Antibacterial Peptide Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Animal Antibacterial Peptide Sales by Application (2021-2026) & (K Tons) Table 64. Europe Animal Antibacterial Peptide Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Animal Antibacterial Peptide Sales by Application (2021-2026) & (K Tons) Table 66. Asia-Pacific Animal Antibacterial Peptide Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Animal Antibacterial Peptide Sales by Application (2021-2026) & (K Tons) Table 68. Latin America Animal Antibacterial Peptide Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Animal Antibacterial Peptide Sales by Application (2021-2026) & (K Tons) Table 70. Middle East and Africa Animal Antibacterial Peptide Sales by Application (2021-2026) & (US$ Million) Table 71. Animal Medics Company Information Table 72. Animal Medics Business Overview Table 73. Animal Medics Animal Antibacterial Peptide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Animal Medics Animal Antibacterial Peptide Product Portfolio Table 75. Animal Medics Recent Development Table 76. Biogenesis Bago Company Information Table 77. Biogenesis Bago Business Overview Table 78. Biogenesis Bago Animal Antibacterial Peptide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Biogenesis Bago Animal Antibacterial Peptide Product Portfolio Table 80. Biogenesis Bago Recent Development Table 81. Boehringer Ingelheim Vetmedica Company Information Table 82. Boehringer Ingelheim Vetmedica Business Overview Table 83. Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Product Portfolio Table 85. Boehringer Ingelheim Vetmedica Recent Development Table 86. Elanco (Eli Lilly and Company) Company Information Table 87. Elanco (Eli Lilly and Company) Business Overview Table 88. Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Product Portfolio Table 90. Elanco (Eli Lilly and Company) Recent Development Table 91. Merial Company Information Table 92. Merial Business Overview Table 93. Merial Animal Antibacterial Peptide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Merial Animal Antibacterial Peptide Product Portfolio Table 95. Merial Recent Development Table 96. Zoetis Company Information Table 97. Zoetis Business Overview Table 98. Zoetis Animal Antibacterial Peptide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Zoetis Animal Antibacterial Peptide Product Portfolio Table 100. Zoetis Recent Development Table 101. Bayer HealthCare Company Information Table 102. Bayer HealthCare Business Overview Table 103. Bayer HealthCare Animal Antibacterial Peptide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Bayer HealthCare Animal Antibacterial Peptide Product Portfolio Table 105. Bayer HealthCare Recent Development Table 106. Merck Animal Health Company Information Table 107. Merck Animal Health Business Overview Table 108. Merck Animal Health Animal Antibacterial Peptide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Merck Animal Health Animal Antibacterial Peptide Product Portfolio Table 110. Merck Animal Health Recent Development Table 111. North America Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 112. North America Animal Antibacterial Peptide Sales by Country (2021-2026) & (K Tons) Table 113. North America Animal Antibacterial Peptide Sales Market Share by Country (2021-2026) Table 114. North America Animal Antibacterial Peptide Sales Forecast by Country (2027-2032) & (K Tons) Table 115. North America Animal Antibacterial Peptide Sales Market Share Forecast by Country (2027-2032) Table 116. North America Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Animal Antibacterial Peptide Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Animal Antibacterial Peptide Market Share by Country (2021-2026) Table 119. North America Animal Antibacterial Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Animal Antibacterial Peptide Market Share Forecast by Country (2027-2032) Table 121. Europe Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 122. Europe Animal Antibacterial Peptide Sales by Country (2021-2026) & (K Tons) Table 123. Europe Animal Antibacterial Peptide Sales Market Share by Country (2021-2026) Table 124. Europe Animal Antibacterial Peptide Sales Forecast by Country (2027-2032) & (K Tons) Table 125. Europe Animal Antibacterial Peptide Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Animal Antibacterial Peptide Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Animal Antibacterial Peptide Market Share by Country (2021-2026) Table 129. Europe Animal Antibacterial Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Animal Antibacterial Peptide Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Animal Antibacterial Peptide Sales by Country (2021-2026) & (K Tons) Table 133. Asia-Pacific Animal Antibacterial Peptide Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Animal Antibacterial Peptide Sales Forecast by Country (2027-2032) & (K Tons) Table 135. Asia-Pacific Animal Antibacterial Peptide Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Animal Antibacterial Peptide Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Animal Antibacterial Peptide Market Share by Country (2021-2026) Table 139. Asia-Pacific Animal Antibacterial Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Animal Antibacterial Peptide Market Share Forecast by Country (2027-2032) Table 141. Latin America Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 142. Latin America Animal Antibacterial Peptide Sales by Country (2021-2026) & (K Tons) Table 143. Latin America Animal Antibacterial Peptide Sales Market Share by Country (2021-2026) Table 144. Latin America Animal Antibacterial Peptide Sales Forecast by Country (2027-2032) & (K Tons) Table 145. Latin America Animal Antibacterial Peptide Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Animal Antibacterial Peptide Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Animal Antibacterial Peptide Market Share by Country (2021-2026) Table 149. Latin America Animal Antibacterial Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Animal Antibacterial Peptide Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Animal Antibacterial Peptide Sales by Country (2021-2026) & (K Tons) Table 153. Middle East and Africa Animal Antibacterial Peptide Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Animal Antibacterial Peptide Sales Forecast by Country (2027-2032) & (K Tons) Table 155. Middle East and Africa Animal Antibacterial Peptide Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Animal Antibacterial Peptide Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Animal Antibacterial Peptide Market Share by Country (2021-2026) Table 159. Middle East and Africa Animal Antibacterial Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Animal Antibacterial Peptide Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Animal Antibacterial Peptide Distributors List Table 164. Animal Antibacterial Peptide Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Animal Antibacterial Peptide Image Figure 2. Global Animal Antibacterial Peptide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Antibacterial Peptide Market Size (2021-2032) & (US$ Million) Figure 4. Global Animal Antibacterial Peptide Sales (2021-2032) & (K Tons) Figure 5. Anionic Peptides Image Figure 6. Global Anionic Peptides Sales YoY Growth (2021-2032) & (K Tons) Figure 7. Cationic Peptide Image Figure 8. Global Cationic Peptide Sales YoY Growth (2021-2032) & (K Tons) Figure 9. Global Animal Antibacterial Peptide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Animal Antibacterial Peptide Market Share by Type 2025 VS 2032 Figure 11. North America Animal Antibacterial Peptide Sales Market Share in Volume by Type in 2025 Figure 12. North America Animal Antibacterial Peptide Sales Market Share in Value by Type in 2025 Figure 13. Europe Animal Antibacterial Peptide Sales Market Share in Volume by Type in 2025 Figure 14. Europe Animal Antibacterial Peptide Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Animal Antibacterial Peptide Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Animal Antibacterial Peptide Sales Market Share in Value by Type in 2025 Figure 17. Latin America Animal Antibacterial Peptide Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Animal Antibacterial Peptide Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Animal Antibacterial Peptide Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Animal Antibacterial Peptide Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Animal Antibacterial Peptide Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Poultry Image Figure 24. Global Poultry Sales YoY Growth (2021-2032) & (K Tons) Figure 25. Livestock Image Figure 26. Global Livestock Sales YoY Growth (2021-2032) & (K Tons) Figure 27. Global Animal Antibacterial Peptide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Animal Antibacterial Peptide Market Share by Application 2025 VS 2032 Figure 29. North America Animal Antibacterial Peptide Sales Market Share in Volume by Application in 2025 Figure 30. North America Animal Antibacterial Peptide Sales Market Share in Value by Application in 2025 Figure 31. Europe Animal Antibacterial Peptide Sales Market Share in Volume by Application in 2025 Figure 32. Europe Animal Antibacterial Peptide Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Animal Antibacterial Peptide Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Animal Antibacterial Peptide Sales Market Share in Value by Application in 2025 Figure 35. Latin America Animal Antibacterial Peptide Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Animal Antibacterial Peptide Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Animal Antibacterial Peptide Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Animal Antibacterial Peptide Sales Market Share in Value by Application in 2025 Figure 39. North America Animal Antibacterial Peptide Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 40. North America Animal Antibacterial Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Animal Antibacterial Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Animal Antibacterial Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Animal Antibacterial Peptide Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 44. Europe Animal Antibacterial Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Animal Antibacterial Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Animal Antibacterial Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Animal Antibacterial Peptide Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 48. Asia-Pacific Animal Antibacterial Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Animal Antibacterial Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Animal Antibacterial Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Animal Antibacterial Peptide Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 52. Latin America Animal Antibacterial Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Animal Antibacterial Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Animal Antibacterial Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Animal Antibacterial Peptide Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 56. Middle East and Africa Animal Antibacterial Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Animal Antibacterial Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Animal Antibacterial Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Animal Antibacterial Peptide Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Animal Antibacterial Peptide Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Anionic Peptides
  • Cationic Peptide
Applications
  • Poultry
  • Livestock
Companies covered
  • Animal Medics
  • Biogenesis Bago
  • Boehringer Ingelheim Vetmedica
  • Elanco (Eli Lilly and Company)
  • Merial
  • Zoetis
  • Bayer HealthCare
  • Merck Animal Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Animal Antibacterial Peptide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Animal Antibacterial Peptide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Animal Antibacterial Peptide Market by Type
  6. 1.3.1 Anionic Peptides
  7. 1.3.2 Cationic Peptide
  8. 1.4 Global Animal Antibacterial Peptide Market Size by Type
  9. 1.4.1 Global Animal Antibacterial Peptide Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Animal Antibacterial Peptide Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Animal Antibacterial Peptide Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Animal Antibacterial Peptide Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Animal Antibacterial Peptide Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Animal Antibacterial Peptide Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Animal Antibacterial Peptide Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Animal Antibacterial Peptide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Animal Antibacterial Peptide Industry Trends
  2. 2.2 Animal Antibacterial Peptide Industry Drivers
  3. 2.3 Animal Antibacterial Peptide Industry Opportunities and Challenges
  4. 2.4 Animal Antibacterial Peptide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Animal Antibacterial Peptide Revenue (2021-2026)
  2. 3.2 Global Top Players by Animal Antibacterial Peptide Sales (2021-2026)
  3. 3.3 Global Top Players by Animal Antibacterial Peptide Price (2021-2026)
  4. 3.4 Global Animal Antibacterial Peptide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Animal Antibacterial Peptide Major Company Production Sites & Headquarters
  6. 3.6 Global Animal Antibacterial Peptide Company, Product Type & Application
  7. 3.7 Global Animal Antibacterial Peptide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Animal Antibacterial Peptide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Animal Antibacterial Peptide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Animal Antibacterial Peptide Tier 1, Tier 2, and Tier 3
4 Animal Antibacterial Peptide Regional Status and Outlook
  1. 4.1 Global Animal Antibacterial Peptide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Animal Antibacterial Peptide Historic Market Size by Region
  3. 4.2.1 Global Animal Antibacterial Peptide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Animal Antibacterial Peptide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Animal Antibacterial Peptide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Animal Antibacterial Peptide Forecasted Market Size by Region
  7. 4.3.1 Global Animal Antibacterial Peptide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Animal Antibacterial Peptide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Animal Antibacterial Peptide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Animal Antibacterial Peptide by Application
  1. 5.1 Animal Antibacterial Peptide Market by Application
  2. 5.1.1 Poultry
  3. 5.1.2 Livestock
  4. 5.2 Global Animal Antibacterial Peptide Market Size by Application
  5. 5.2.1 Global Animal Antibacterial Peptide Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Animal Antibacterial Peptide Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Animal Antibacterial Peptide Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Animal Antibacterial Peptide Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Animal Antibacterial Peptide Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Animal Antibacterial Peptide Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Animal Antibacterial Peptide Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Animal Antibacterial Peptide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Animal Medics
  2. 6.1.1 Animal Medics Company Information
  3. 6.1.2 Animal Medics Business Overview
  4. 6.1.3 Animal Medics Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Animal Medics Animal Antibacterial Peptide Product Portfolio
  6. 6.1.5 Animal Medics Recent Developments
  7. 6.2 Biogenesis Bago
  8. 6.2.1 Biogenesis Bago Company Information
  9. 6.2.2 Biogenesis Bago Business Overview
  10. 6.2.3 Biogenesis Bago Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biogenesis Bago Animal Antibacterial Peptide Product Portfolio
  12. 6.2.5 Biogenesis Bago Recent Developments
  13. 6.3 Boehringer Ingelheim Vetmedica
  14. 6.3.1 Boehringer Ingelheim Vetmedica Company Information
  15. 6.3.2 Boehringer Ingelheim Vetmedica Business Overview
  16. 6.3.3 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Vetmedica Recent Developments
  19. 6.4 Elanco (Eli Lilly and Company)
  20. 6.4.1 Elanco (Eli Lilly and Company) Company Information
  21. 6.4.2 Elanco (Eli Lilly and Company) Business Overview
  22. 6.4.3 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Product Portfolio
  24. 6.4.5 Elanco (Eli Lilly and Company) Recent Developments
  25. 6.5 Merial
  26. 6.5.1 Merial Company Information
  27. 6.5.2 Merial Business Overview
  28. 6.5.3 Merial Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merial Animal Antibacterial Peptide Product Portfolio
  30. 6.5.5 Merial Recent Developments
  31. 6.6 Zoetis
  32. 6.6.1 Zoetis Company Information
  33. 6.6.2 Zoetis Business Overview
  34. 6.6.3 Zoetis Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Zoetis Animal Antibacterial Peptide Product Portfolio
  36. 6.6.5 Zoetis Recent Developments
  37. 6.7 Bayer HealthCare
  38. 6.7.1 Bayer HealthCare Company Information
  39. 6.7.2 Bayer HealthCare Business Overview
  40. 6.7.3 Bayer HealthCare Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bayer HealthCare Animal Antibacterial Peptide Product Portfolio
  42. 6.7.5 Bayer HealthCare Recent Developments
  43. 6.8 Merck Animal Health
  44. 6.8.1 Merck Animal Health Company Information
  45. 6.8.2 Merck Animal Health Business Overview
  46. 6.8.3 Merck Animal Health Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merck Animal Health Animal Antibacterial Peptide Product Portfolio
  48. 6.8.5 Merck Animal Health Recent Developments
7 North America by Country
  1. 7.1 North America Animal Antibacterial Peptide Sales by Country
  2. 7.1.1 North America Animal Antibacterial Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Animal Antibacterial Peptide Sales by Country (2021-2026)
  4. 7.1.3 North America Animal Antibacterial Peptide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Animal Antibacterial Peptide Market Size by Country
  6. 7.2.1 North America Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Animal Antibacterial Peptide Market Size by Country (2021-2026)
  8. 7.2.3 North America Animal Antibacterial Peptide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Animal Antibacterial Peptide Sales by Country
  2. 8.1.1 Europe Animal Antibacterial Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Animal Antibacterial Peptide Sales by Country (2021-2026)
  4. 8.1.3 Europe Animal Antibacterial Peptide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Animal Antibacterial Peptide Market Size by Country
  6. 8.2.1 Europe Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Animal Antibacterial Peptide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Animal Antibacterial Peptide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Animal Antibacterial Peptide Sales by Country
  2. 9.1.1 Asia-Pacific Animal Antibacterial Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Animal Antibacterial Peptide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Animal Antibacterial Peptide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Animal Antibacterial Peptide Market Size by Country
  6. 9.2.1 Asia-Pacific Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Animal Antibacterial Peptide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Animal Antibacterial Peptide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Animal Antibacterial Peptide Sales by Country
  2. 10.1.1 South America Animal Antibacterial Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Animal Antibacterial Peptide Sales by Country (2021-2026)
  4. 10.1.3 South America Animal Antibacterial Peptide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Animal Antibacterial Peptide Market Size by Country
  6. 10.2.1 South America Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Animal Antibacterial Peptide Market Size by Country (2021-2026)
  8. 10.2.3 South America Animal Antibacterial Peptide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Animal Antibacterial Peptide Sales by Country
  2. 11.1.1 Middle East and Africa Animal Antibacterial Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Animal Antibacterial Peptide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Animal Antibacterial Peptide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Animal Antibacterial Peptide Market Size by Country
  6. 11.2.1 Middle East and Africa Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Animal Antibacterial Peptide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Animal Antibacterial Peptide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Animal Antibacterial Peptide Value Chain Analysis
  2. 12.1.1 Animal Antibacterial Peptide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Animal Antibacterial Peptide Production Mode & Process
  7. 12.2 Animal Antibacterial Peptide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Animal Antibacterial Peptide Distributors
  10. 12.2.3 Animal Antibacterial Peptide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst